Study in Healthy Adults Evaluating PF-07202954
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)
- Status
- COMPLETED
- Phase
- PHASE1
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern California
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention
- Status
- TERMINATED
- Phase
- PHASE2
Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
- Status
- COMPLETED
- Phase
- PHASE3
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy
- Status
- COMPLETED
- Phase
- PHASE1
Comorbidities And Reducing inEquitieS
- Status
- COMPLETED
- Phase
- NA
A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device
- Status
- TERMINATED
- Phase
- PHASE1
The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients
- Status
- COMPLETED
- Phase
- PHASE4
Telaglenastat + Talazoparib In Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Monitoring Activity And Gait In Children
- Status
- COMPLETED
- Phase
- N/A
A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
- Status
- COMPLETED
- Phase
- N/A
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children
- Status
- COMPLETED
- Phase
- PHASE3